| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
CooperCompanies (NASDAQ:COO), a leading global medical device company, announced today its Board of Directors has approved a $1 billion increase in the Company's share repurchase program. The share repurchase program now totals $2 billion.
Posted In: COO